VYNE Therapeutics (VYNE) Property, Plant & Equipment (Net) (2016 - 2026)

VYNE Therapeutics (VYNE) Property, Plant & Equipment (Net) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 VYNE Therapeutics 1.19 Bn 1.16 Bn - 84,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 84,000.00
Mar 31, 2026 84,000.00
Dec 31, 2025 90,000.00
Dec 31, 2025 90,000.00
Jun 30, 2025 102,000.00
Jun 30, 2025 102,000.00
Mar 31, 2025 107,000.00
Mar 31, 2025 107,000.00
Dec 31, 2024 113,000.00
Dec 31, 2024 113,000.00
Sep 30, 2022 127,000.00
Sep 30, 2022 127,000.00
Jun 30, 2022 298,000.00
Jun 30, 2022 298,000.00
Mar 31, 2022 310,000.00
Mar 31, 2022 310,000.00
Dec 31, 2021 354,000.00
Dec 31, 2021 354,000.00
Sep 30, 2021 472,000.00
Sep 30, 2021 472,000.00